NCT05103878 - A Phase 1, Single-Ascending-Dose Study of BT051 in Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 24, 2020

Primary Completion Date

November 13, 2020

Study Completion Date

November 13, 2020

Conditions

Healthy Volunteers

Interventions

DRUG

BT051 100mg

Single oral dose of 100mg BT051

DRUG

BT051 300mg

Single oral dose of 300mg BT051

DRUG

BT051 700mg

Single oral dose of 700mg BT051

DRUG

BT051 1500mg

Single oral dose of 1500mg BT051

DRUG

BT051 3500mg

Single oral dose of 3500mg BT051

DRUG

Matching Placebo

Placebo Matching BT051

Trial Locations (1)

Spaulding Clinical Research, LLC, West Bend